Evidence map›Paper›PMID 40006891›Full record

ArticleViruses2025

Characterization of Endogenous Retroviral-like Particles Expressed from the

Hailun Ma, Eunhae H Bae, Pei-Ju Chin, Arifa S Khan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hailun MaDivision of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
Eunhae H BaeNorthwest Regional Campus, University of Arkansas for Medical Sciences, 1125 N. College Ave, Fayetteville, AR 72703, USA.
Pei-Ju ChinDivision of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
Arifa S KhanDivision of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Endogenous RetrovirusesSpodopteraVirionAnimalsBaculoviridaeCell LineParticle SizeRNA-Directed DNA PolymeraseSf9 CellsRNA-Directed DNA Polymerasechemical inductioncryo-electron microscopy (cryoEM)endogenous retroviral-like particles (RVLPs)extracellular vesicles (EVs)infectivity assayPCR-enhanced RT (PERT) assayreverse transcriptase (RT)Sf9 cell lineSpodoptera frugiperdatransmission electron microscopy (TEM)

Identifiers

PMID40006891
PMCPMC11860259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.